Sponsored

The fourth Amendment of the China Patent Law has been deliberated and was passed on October 17, 2020. It will come into force on June 1, 2021. For the medical industry, China’s proposed patent linkage system can be more favorable to generic drug companies than the U.S. system.

October is Breast Cancer Awareness month, and Daiichi Sankyo is aiming to raise awareness about one of the most common forms of cancer across the globe.

A look at how two biotech professionals made the transition from research to inspiring students as biotech teachers with the help of EnCorps STEM Teachers Program.

Saurabh Kapure, Vice President, Business Development, USA for Jubilant Biosys, recently sat down with Bob Volkmann, PhD, Founder and Chief Scientific Officer, at BioPharmaWorks.

In China, much like the United States, it is incredibly difficult to obtain a patent for a diagnostic method.

Today, one thing is crystal clear: change is the new normal in the life sciences industry. Organizations are looking for leaders who are future-focused and able to handle whatever comes their way. Maintaining the status quo is no longer good enough.

Together with its Körber partner companies, Werum is working on solutions that help streamline the complex cell and gene therapy workflows and enable delivery at scale of these critical, life-saving and personalized medicines.

Together with its Körber partner companies, Werum is working on solutions that help streamline the complex cell and gene therapy workflows and enable delivery at scale of these critical, life-saving and personalized medicines.

Mesothelioma is a rare cancer that develops in the lining of the lungs, abdomen, or cardiovascular cavity. A 2017 study reported that the number of people affected by this rare cancer is between 2,400 - 2,800 individuals per year in the United States alone.

Days before his sentencing for a criminal fraud conviction disgraced pharma entrepreneur Martin Shkreli has been ordered to forfeit $7.36 million.